Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CFF-1 is a **Traditional Chinese Medicine formulation** reported in the literature as an investigational therapy for **prostate cancer**. Based on the provided publication, it is a **multi-component herbal combination** rather than a single defined molecular entity, with network pharmacology and cell-based experiments suggesting anti-tumor effects including inhibition of prostate cancer cell proliferation, migration, and invasion, and induction of apoptosis. Its proposed activity appears to be **polypharmacologic**, with pathway-level effects involving **PI3K-Akt, HIF-1, TNF, EGFR-TKI resistance, and PD-1 checkpoint signaling**, but no single validated primary molecular target or commercial developer is clearly established from the supplied evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CFF-1.